Literature DB >> 21113280

Patients in Northwestern Turkey Prefer Herbs as Complementary Medicine after Breast Cancer Diagnosis.

Bahadir M Gulluoglu1, Asim Cingi, Tebessum Cakir, Afsar Barlas.   

Abstract

BACKGROUND: A cross-sectional survey was conducted in order to define the prevalence, pattern, and predictors of complementary and alternative medicine (CAM) use in breast cancer patients in northwestern Turkey. PATIENTS AND METHODS: All patients admitted to the breast center between January 2005 and January 2006 were consecutively included in the study. Demographics and clinical data of study patients were noted. A 15-item questionnaire was used to document the attitude of breast cancer patients towards CAM modalities. Primary outcomes were prevalence, pattern, and predictors of CAM. Secondary outcomes were the reasons for CAM use, the number and type of adverse events related to CAM use, and the satisfaction level of CAM users.
RESULTS: Nearly one third of breast cancer patients use at least one type of CAM in addition to conventional therapy. Most chose herbal medicines which they think support their general health status. Nettle (Urtica diocia/U. urens) was the most common herbal medicine that patients consume. Previous experience with CAM was the most significant factor for CAM use after breast cancer diagnosis. Being young and married as well as receiving radiotherapy were among other independent factors for using any CAM modality.

Entities:  

Year:  2008        PMID: 21113280      PMCID: PMC2974983          DOI: 10.1159/000144045

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  20 in total

Review 1.  Complementary and alternative medicine in early-stage breast cancer.

Authors:  M Tagliaferri; I Cohen; D Tripathy
Journal:  Semin Oncol       Date:  2001-02       Impact factor: 4.929

2.  Knowledge of and attitudes toward complementary and alternative therapies; a national multicentre study of oncology professionals in Norway.

Authors:  T Risberg; A Kolstad; Y Bremnes; H Holte; E A Wist; O Mella; O Klepp; T Wilsgaard; B R Cassileth
Journal:  Eur J Cancer       Date:  2004-03       Impact factor: 9.162

3.  Complementary/alternative medicine use in a pediatric oncology unit in Turkey.

Authors:  Ceyda Karadeniz; F Güçlü Pinarli; Aynur Oğuz; Türkiz Gürsel; Berna Canter
Journal:  Pediatr Blood Cancer       Date:  2007-05       Impact factor: 3.167

4.  Use of alternative medicine by women with early-stage breast cancer.

Authors:  H J Burstein; S Gelber; E Guadagnoli; J C Weeks
Journal:  N Engl J Med       Date:  1999-06-03       Impact factor: 91.245

5.  The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients.

Authors:  Faruk Tas; Zeki Ustuner; Gulbeyaz Can; Yesim Eralp; Hakan Camlica; Mert Basaran; Hakan Karagol; Burak Sakar; Rian Disci; Erkan Topuz
Journal:  Acta Oncol       Date:  2005       Impact factor: 4.089

6.  Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions.

Authors:  H Boon; M Stewart; M A Kennard; R Gray; C Sawka; J B Brown; C McWilliam; A Gavin; R A Baron; D Aaron; T Haines-Kamka
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

7.  Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.

Authors:  M A Richardson; T Sanders; J L Palmer; A Greisinger; S E Singletary
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

8.  Use of complementary and alternative medicine in cancer patients: a European survey.

Authors:  A Molassiotis; P Fernández-Ortega; D Pud; G Ozden; J A Scott; V Panteli; A Margulies; M Browall; M Magri; S Selvekerova; E Madsen; L Milovics; I Bruyns; G Gudmundsdottir; S Hummerston; A M-A Ahmad; N Platin; N Kearney; E Patiraki
Journal:  Ann Oncol       Date:  2005-02-02       Impact factor: 32.976

Review 9.  Risks and benefits of commonly used herbal medicines in Mexico.

Authors:  Lourdes Rodriguez-Fragoso; Jorge Reyes-Esparza; Scott W Burchiel; Dea Herrera-Ruiz; Eliseo Torres
Journal:  Toxicol Appl Pharmacol       Date:  2007-10-12       Impact factor: 4.219

10.  The use of complementary and alternative medicines among patients with locally advanced breast cancer--a descriptive study.

Authors:  Lucy K Helyer; Stephen Chin; Betty K Chui; Barbara Fitzgerald; Sunil Verma; Eileen Rakovitch; George Dranitsaris; Mark Clemons
Journal:  BMC Cancer       Date:  2006-02-21       Impact factor: 4.430

View more
  5 in total

Review 1.  Complementary and alternative therapies used by Turkish breast cancer patients undergoing chemotherapy.

Authors:  Gulbeyaz Can; Melike Demir; Adnan Aydiner
Journal:  Breast Care (Basel)       Date:  2012-12       Impact factor: 2.860

2.  Expectations from an integrative medicine consultation in breast cancer care: a registry protocol-based study.

Authors:  Noah Samuels; Elad Schiff; Ofer Lavie; Orit Gressel Raz; Eran Ben-Arye
Journal:  Support Care Cancer       Date:  2014-07-30       Impact factor: 3.603

Review 3.  Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.

Authors:  John Baptist Asiimwe; Prakash B Nagendrappa; Esther C Atukunda; Mauda M Kamatenesi; Grace Nambozi; Casim U Tolo; Patrick E Ogwang; Ahmed M Sarki
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-17       Impact factor: 2.650

Review 4.  Medicinal Plants from Near East for Cancer Therapy.

Authors:  Mohammad S Abu-Darwish; Thomas Efferth
Journal:  Front Pharmacol       Date:  2018-01-31       Impact factor: 5.810

Review 5.  Complementary and Alternative Medicines and Patients With Breast Cancer: A Case of Mortality and Systematic Review of Patterns of Use in Patients With Breast Cancer.

Authors:  Grayson A Roumeliotis; Genevieve Dostaler; Kirsty U Boyd
Journal:  Plast Surg (Oakv)       Date:  2017-08-22       Impact factor: 0.947

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.